Creatine supplementation decreases homocysteine in an animal model of uremia

Kidney International

Volumn 64, Issue 4, 2003, Pages 1331-1337

  Taes, Youri E C ^a   Delanghe, Joris R ^b   De Vriese, An S ^b   Rombaut, Roeland ^b   Van Camp, John ^b   Lameire, Norbert H ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

5 Methyltetrahydrofolate; Creatine; End stage renal disease; Tetrahydrofolate; Total plasma homocysteine

Indexed keywords

CREATINE; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; TETRAHYDROFOLIC ACID;

AMINO ACID BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; FOLIC ACID BLOOD LEVEL; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; UREMIA; VITAMIN BLOOD LEVEL;

EID: 0141674928     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00206.x     Document Type: Article

References (33)

1. REFSUM H, UELAND PM, NYGÅRD O, VOLLSET SE: Homocysteine and cardiovascular disease. Annu Rev Med 49:31-62, 1998
2. SELHUB J: Homocysteine metabolism. Annu Rev Nutr 19:217-246, 1999
3. DE VRIESE AS, VERBEKE F, SCHRIJVERS BF, LAMEIRE NH: Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? Kidney Int 61:1199-1209, 2002
4. BOSTOM AG, GOHH RY, BEAULIEU AJ, et al: Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med 15:1089-1092, 1997
5. 12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease. Metabolism 48:631-635, 1999
6. MCGREGOR DO, DELLOW WJ, ROBSON RA, et al: Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney Int 61:1040-1046, 2002
7. PERSKY AM, BRAZEAU GA: Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 53:161-176, 2001
8. WYSS M, KADDURAH DAOUK R: Creatine and creatinine metabolism. Physiol Rev 80:1107-1213, 2000
9. WALKER JB: Creatine: Biosynthesis, regulation and function. Adv Enzymol Relat Areas Mol Biol 50:177-242, 1979
10. MUDD SH, POOLE JR: Labile methyl balance for normal humans on various dietary regimes. Metabolism 24:721-735, 1975
11. MUDD SH, EBERT MH, SCRIVER CR: Labile methyl group balances in the human: the role of sarcosine. Metabolism 29:707-739, 1980
12. STEAD LM, AU KP, JACOBS RL, et al: Methylation demand and homocysteine metabolism: Effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metab 281:E1095-E1100, 2001
13. TAES YE, DELANGHE JR, WUYTS B, et al: Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrol Dial Transplant 18:258-264, 2003
14. COMBET S, FERRIER ML, VAN LANDSCHOOT M, et al: Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 12:2146-2157, 2001
15. DELANGHE J, DE SLYPERE JP, DE BUYZERE M, et al: Normal reference values for creatine, creatinine, and carnitine are lower in vegetarians. Clin Chem 35:1802-1803, 1989
16. BERLET HH: Comparative study of various methods for the extraction of free creatine and phosphocreatine from mouse skeletal muscle. Anal Biochem 60:347-357, 1974
17. BERTOLACINI RJ, BARNEY JE: Colorimetric determination of sulfate with barium chloranilate. Anal Chem 29:281-283, 1957
18. VAHTERISTO L, OLLILAINEN V, VARO P: HPLC determination of folate in liver and liver products. J Food Sci 61:524-526, 1996
19. BOSTOM AG, CULLETON BF: Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 10:891-900, 1999
20. KUMAGAI H, KATOH S, HIROSAWA K, et al: Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int 62:1219-1228, 2002
21. STEENGE GR, VERHOEF P, GREENHAFF PL: The effect of creatine and resistance training on plasma homocysteine concentrations in healthy volunteers. Arch Intern Med 161:1455-1456, 2001
22. WYSS M, SCHULZE A: Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112:243-260, 2002
23. EDMUNDS JW, JAYAPALAN S, DIMARCO NM, et al: Creatine supplementation increases renal disease progression in Han:SPRD-cy rats. Am J Kidney Dis 37:73-78, 2001
24. POORTMANS JR, FRANCAUX M: Adverse effects of creatine supplementation. Fact or Fiction? Sports Med 30:155-170, 2000
25. NAKANISHI T, OTAKI Y, HASUIKE Y, et al: Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease. Am J Kidney Dis 40:909-915, 2002
26. BISSOLI L, DI FRANCESCO V, BALLARIN A, et al: Effect of vegetarian diet on homocysteine levels. Ann Nutr Metab 46:73-79, 2002
27. HUNG CJ, HUANG PC, LU SC, et al: Plasma homocysteine levels in Taiwanese vegetarians are higher than those of omnivores. J Nutr 132:152-158, 2002
28. 12, and total antioxidant status in vegetarians. Clin Chem 47:1094-1101, 2001
29. BRATTSTROM L, LINDGREN A, ISRAELSSON B, et al: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236:633-641, 1994
30. GILTAY EJ, HOOGEVEEN EK, ELBERS JMH, et al: Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females. J Clin Endocrinol Metab 83:550-553, 1998
31. BLANDINI F, FANCELLU R, MARTIGNONI E, et al: Homocysteine and L-DOPA metabolism in patients with parkinson disease. Clin Chem 47:1102-1104, 2001
32. BASU TK, MAKHANI N, SEDGWICK G: Niacin (nicotinic acid) in nonphysiological doses causes hyperhomocysteineaemia in Sprague-Dawley rats. Br J Nutr 87:115-119, 2002
33. DESOUZA C, KEEBLER M, MCNAMARA DB, FONSECA V: Drugs affecting homocysteine metabolism: Impact on cardiovascular risk. Drugs 62:605-616, 2002